MetLife (MET) shares have recently declined by nearly 4% over the past month, raising questions about its current valuation despite a strong 87.3% total shareholder return over five years. The stock is currently trading below analyst price targets and appears undervalued at $93 according to Simply Wall St's fair value calculations, driven by assumptions about future margins and revenue growth supported by digital transformation. Investors are weighing the potential upside against risks such as persistent low interest rates or slow technology adoption.

大都會人壽

<p>大都會人壽（MetLife，股票代碼：MET）最近一個月的股價下跌了近 4%，引發了人們對其當前估值的質疑，儘管在過去五年中其總股東回報率達到了 87.3%。根據 Simply Wall St 的公允價值計算，該股票目前的交易價格為 93 美元，低於分析師的目標價，似乎被低估，這一估值是基於對未來利潤率和收入增長的假設，這些假設得到了數字化轉型的支持。投資者正在權衡潛在的上漲空間與持續低利率或技術採用緩慢等風險</p>

大都會人壽 (MET)：在近期股價下跌後探討其估值